Hunan Jingfeng Pharmaceutical Co (SZSE:000908) ROCE % : 249.68% (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hunan Jingfeng Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 249.68%.

Hunan Jingfeng Pharmaceutical Co ROCE % Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co ROCE % Chart

Hunan Jingfeng Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-25.44

-54.30

-9.65

-8.49

-68.06

Hunan Jingfeng Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															21.22	8.90	-8.00	-332.58	249.68

Hunan Jingfeng Pharmaceutical Co ROCE % Calculation

Hunan Jingfeng Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-133.734	/	( ( (1457.543 - 1083.361)	+	(1060.346 - 1041.543) )	/ 2 )
	=	-133.734	/	( (374.182	+	18.803)	/ 2 )
	=	-133.734	/	196.4925
	=	-68.06 %

Hunan Jingfeng Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	50.824	/	( ( (1060.346 - 1041.543)	+	(1099.909 - 1078) )	/ 2 )
	=	50.824	/	( ( 18.803	+	21.909 )	/ 2 )
	=	50.824	/	20.356
	=	249.68 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hunan Jingfeng Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN

Website

http://www.jfyiyao.com

Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.

Executives

Zhou Shen Dong	Supervisors
Ye Xiang Wu	Directors, executives
Ma Xian Peng	Executives
Cong Shu Fen	Executives
Zhang Jun Guo	Executives
Jian Wei Guang	Directors, executives
Bi Yuan	Secretary, Director
Ou Yang Yan Li	Secretary, Director
Luo Li	Director
Luo Bin	Director
Li Tong	Directors, executives
Wei Ze Chun	Director
Tang Zhi	Executives
Ou Yang Chun Bao	Executives
Mao Hui	Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines